Daily Morning Note – 20 Aug 2020
Asian stocks looked set for a cautious start Thursday after the dollar climbed and U.S. equities retreated in the wake of the FOMC’s minutes. Futures ticked lower in Japan, Australia and Hong Kong. The S&P 500 erased gains as the Fed noted the coronavirus crisis would “weigh heavily” on economic activity. The greenback advanced after a five-day rout, gold tumbled and Treasuries slipped as policy makers panned yield-curve control. Elsewhere, oil slipped from a five-month high as the OPEC+ alliance urged members to adhere to limiting output as the coronavirus pandemic threatens a demand recovery.
Catalist-listed glove manufacturer UG Healthcare Corporation has proposed to place up to 7.5 million shares at S$2.545 apiece to raise a total sum of S$19.1 million. The placement price represents a discount of about 9.9 per cent to the volume-weighted average price of S$2.8247 for trades done on the Singapore Exchange on Tuesday.
Guocoland is expanding its multi-billion-dollar integrated development on Beach Road, Guoco Midtown, to include a second luxury residential project named Midtown Modern. The condomininum will consist of two 30-storey towers with more than 500 apartments in a forest garden setting, as well as a retail podium, the mainboard-listed property developer announced in a press statement on Thursday.
Quarz Capital Management said on Wednesday that it, together with other minority shareholders, looks forward to receiving guidance and support from the Monetary Authority of Singapore (MAS) and the Singapore Exchange Regulation (SGX Regco) on the proposed merger between Sabana Shari’ah Compliant Industrial Real Estate Investment Trust (Sabana Reit) and ESR-Reit.
The Singapore Exchange Regulation (SGX RegCo) on Wednesday released an inaugural publication, Findings and Recommendations on Continuing Sponsorship Work, which aims to highlight areas for improvement following its observations of reviews and inspections of sponsors on the Catalist board.
Millennium Hotels and Resorts (MHR) cut 159 jobs, or about 15 per cent of its Singapore-based workforce, on Wednesday amid weak tourism demand due to the Covid-19 pandemic.
Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, PSR
Wilmar International Ltd
Analyst: Chua Wei Ren
Recommended Action: Technical BUY
Wilmar International (SGX: F34) bullish strength has beat our target price based on our report dated 7th July and the technical suggest that the stock will make a higher high beyond $5.00.
Hyphens Pharma International Ltd – Shaking off COVID-19 woes with expanded portfolio
Recommendation: ACCUMULATE (Maintained); Last Done: S$0.450
Target Price: S$0.495; Analyst: Tay Wee Kuang
– Earnings of S$4.28mn make up 64% of our FY20e estimates.
– Revenue growth of 10% YoY in 1H20 was held up by an all-around stronger 1Q20 result as well as a 24% growth YoY in revenue from proprietary brands in 2Q20.
– Cash flow for 1H20 was down S$1.7mn as inventory levels were elevated in anticipation of disruptions arising from product license renewals in Vietnam.
– Group continues to invest into building its proprietary brands portfolio with acquisition of haircare product CG 210® and new product launches across its Ceradan® and Ocean Health® brand portfolio.
– Maintain ACCUMULATE with upward revision in TP to S$0.495 (prev S$0.435). We revise FY20e earnings upwards by 25% to reflect strong revenue growth and income recognised from Job Support Scheme in 2H20.
HK Reports – Read up on our Hong Kong reports here
Webinar Of The Week
Date: 17 August 2020
|The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.|
|This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.|